Your session is about to expire
← Back to Search
Pridopidine for Amyotrophic Lateral Sclerosis
Study Summary
This trial is testing a drug called pridopidine to see if it is safe and effective in treating people with ALS.
- ALS (Amyotrophic Lateral Sclerosis)
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2022 Phase 2 & 3 trial • 163 Patients • NCT04615923Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Has Pridopidine been used in other scientific research projects before?
"There are currently 3 clinical trials for Pridopidine with 1 being in Phase 3. With the majority of the research taking place in Boston, Massachusetts, there are a total of 127 locations running trials for Pridopidine."
Is this research project enrolling new participants at this time?
"This particular trial is not currently seeking patients. The original posting was on December 18th, 2020 and the most recent update was on September 18th, 2022. There are, however, 135 other clinical trials for amyotrophic lateral sclerosis and 3 for Pridopidine that are actively recruiting participants."
How many human subjects are involved in this clinical trial?
"Enrollment for this study has been paused; it was originally posted on December 18th, 2020. The last update to the study was on September 18th, 2022. There are presently 135 studies actively recruiting patients with amyotrophic lateral sclerosis and 3 trials for Pridopidine searching for eligible participants."
Who else is applying?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger